|
|
|
International Clinical Trials
|
Acceleration of the integration of mobile health (mHealth) technologies into clinical trial operations is expected to be the catalyst for the adoption of disruptive research platforms with capabilities to overcome barriers in both clinically mature and emerging markets. While mHealth applications of smart devices, wearable biometric sensors, and telemedicine enable health monitoring, data collection, and patient communications have been around for some time. Despite this, their widespread use in clinical research should still be considered in its infancy. We continue to see the fast development of integrated mHealth platforms that have the potential to turn the traditional research model on its head – taking studies to patients rather than bringing patients into site-based studies. Powered by Big Data and connected across patients, researchers, and caregivers, emerging mHealth platforms will expand research participation, reduce costs, and integrate research with treatment in new models of personalised medicine based on real-world evidence.
The mHealth Disruption Four foundational trends are driving 21st century biomedical research:
- Globalisation is expanding drug development into the emerging markets of Africa, Asia, and Latin America
- Big Data is being harnessed to understand disease impacts at the population level and support evidence-based medical practice
- Real-world evaluation is extending the continuum from traditional randomised clinical trials to new research models that assess real-world outcomes
- Personalised medicine is advancing with targeted therapies tailored to smaller populations and the growth of patientcentric research
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Sharp announces preferred partner agreement with Berkshire Sterile Manufacturing
Sharp, a global leader in contract packaging and clinical supply services, part of UDG Healthcare plc, has confirmed a preferred partner agreement with innovative sterile manufacturer Berkshire Sterile Manufacturing (BSM).
More info >> |
|
 |
White Papers |
 |
|
The Key To Tableting Success: How To Choose The Right Tooling
Natoli Engineering Company, Inc.
Choosing the right tooling can increase tablet output, decrease waste and ultimately determine the success of a product launch.
More info >> |
|
 |
Industry Events |
 |
Clinical Trial Supply Europe 2019
13-14 March 2019, Milan, Italy
Following
on from our largest and most engaging meeting to date, Clinical Trial Supply
Europe will be returning to Milan for its 20th year in 2019!
The
19th annual edition welcomed pharmaceutical companies across Europe who got
together to share knowledge and issues regarding clinical trial supplies, both
with regards to operational and technological challenges. Over the two days,
delegates discussed issues which affected their business in our dedicated
operational and technological streams.
More info >> |
|
|
